Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 100
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Cotton, S. M. Filia, K. M. Ratheesh, A. Pennell, K. Goldstone, S. and McGorry, P. D. 2016. Early psychosis research at Orygen, The National Centre of Excellence in Youth Mental Health. Social Psychiatry and Psychiatric Epidemiology, Vol. 51, Issue. 1, p. 1.

    Hutton, Paul 2016. The Wiley Handbook of Positive Clinical Psychology.

    Porcelli, Stefano Bianchini, Oriana De Girolamo, Giovanni Aguglia, Eugenio Crea, Luciana and Serretti, Alessandro 2016. Clinical factors related to schizophrenia relapse. International Journal of Psychiatry in Clinical Practice, Vol. 20, Issue. 2, p. 54.

    Gumley, Andrew I. MacBeth, Angus Reilly, James D. O'Grady, Margaret White, Ross G. McLeod, Hamish Schwannauer, Matthias and Power, Kevin G. 2015. Fear of recurrence: Results of a randomized trial of relapse detection in schizophrenia. British Journal of Clinical Psychology, Vol. 54, Issue. 1, p. 49.

    Velthorst, E. Koeter, M. van der Gaag, M. Nieman, D. H. Fett, A.-K. J. Smit, F. Staring, A. B. P. Meijer, C. and de Haan, L. 2015. Adapted cognitive–behavioural therapy required for targeting negative symptoms in schizophrenia: meta-analysis and meta-regression. Psychological Medicine, Vol. 45, Issue. 03, p. 453.

    2015. Therapie Psychischer Erkrankungen.

    Bouchard, Jean-Pierre 2014. Intérêt curatif et préventif des thérapies cognitives et comportementales (TCC) dans le traitement de croyances délirantes schizophréniques criminogènes : TCC d’une conviction délirante ayant généré un double homicide à l’extérieur de la famille. Annales Médico-psychologiques, revue psychiatrique, Vol. 172, Issue. 9, p. 741.

    Dopke, Cynthia A. and Batscha, Catherine L. 2014. Cognitive-Behavioral Therapy for Individuals with Schizophrenia: A Recovery Approach. American Journal of Psychiatric Rehabilitation, Vol. 17, Issue. 1, p. 44.

    Eisner, Emily Barrowclough, Christine Lobban, Fiona and Drake, Richard 2014. Qualitative investigation of targets for and barriers to interventions to prevent psychosis relapse. BMC Psychiatry, Vol. 14, Issue. 1,

    García Valencia, Jenny Ahunca Velásquez, Luisa Fernanda Bohórquez Peñaranda, Adriana Gómez Restrepo, Carlos Jaramillo González, Luis Eduardo and Palacio Acosta, Carlos 2014. Tratamiento con intervenciones psicoterapéuticas en la fase aguda y de mantenimiento del paciente adulto con diagnóstico de esquizofrenia. Revista Colombiana de Psiquiatría, Vol. 44, p. 90.

    Jauhar, S. McKenna, P. J. Radua, J. Fung, E. Salvador, R. and Laws, K. R. 2014. Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. The British Journal of Psychiatry, Vol. 204, Issue. 1, p. 20.

    Kauermann, Göran and Norrie, John 2014. Wiley StatsRef: Statistics Reference Online.

    McKenna, Peter J and Mortimer, Ann M 2014. Current and future treatment modalities in schizophrenia: novel antipsychotic drugs and cognitive therapy. Expert Review of Neurotherapeutics, Vol. 14, Issue. 1, p. 67.

    Thomas, Neil Shawyer, Frances Castle, David J Copolov, David Hayes, Steven C and Farhall, John 2014. A randomised controlled trial of acceptance and commitment therapy (ACT) for psychosis: study protocol. BMC Psychiatry, Vol. 14, Issue. 1,

    2014. Therapie Psychischer Erkrankungen.

    Bebbington, Paul Kuipers, Elizabeth and Fowler, David 2013. Improving Mental Health Care.

    Eisner, Emily Drake, Richard and Barrowclough, Christine 2013. Assessing early signs of relapse in psychosis: Review and future directions. Clinical Psychology Review, Vol. 33, Issue. 5, p. 637.

    Elis, Ori Caponigro, Janelle M. and Kring, Ann M. 2013. Psychosocial treatments for negative symptoms in schizophrenia: Current practices and future directions. Clinical Psychology Review, Vol. 33, Issue. 8, p. 914.

    Gleeson, J. F. M. Cotton, S. M. Alvarez-Jimenez, M. Wade, D. Gee, D. Crisp, K. Pearce, T. Spiliotacopoulos, D. Newman, B. and McGorry, P. D. 2013. A Randomized Controlled Trial of Relapse Prevention Therapy for First-Episode Psychosis Patients: Outcome at 30-Month Follow-Up. Schizophrenia Bulletin, Vol. 39, Issue. 2, p. 436.

    Harper, Sean F. 2013. Integrating Theories and Concepts: Formulation Driven CBT for a Client with a Diagnosis of Schizo-Affective Disorder. Clinical Psychology & Psychotherapy, Vol. 20, Issue. 1, p. 77.


Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy

  • A. GUMLEY (a1), M. O'GRADY (a1), L. MCNAY (a1), J. REILLY (a1), K. POWER (a1) and J. NORRIE (a1)
  • DOI:
  • Published online: 01 April 2003

Background. The paper describes a randomized controlled trial of targeting cognitive behavioural therapy (CBT) during prodromal or early signs of relapse in schizophrenia. We hypothesized that CBT would result in reduced admission and relapse, reduced positive and negative symptoms, and improved social functioning.

Method. A total of 144 participants with schizophrenia or a related disorder were randomized to receive either treatment as usual (TAU) (N=72) or CBT+TAU (N=72). Participants were prospectively followed up between entry and 12 months.

Results. At 12 months, 11 (15·3%) participants in the CBT group were admitted to hospital compared to 19 (26·4%) of the TAU group (hazard ratio=0·53, P=0·10, 95% CI 0·25, 1·10). A total of 13 (18·1%) participants in CBT relapsed compared to 25 (34·7%) in TAU (hazard ratio=0·47, P<0·05, 95% CI 0·24, 0·92). In addition, the CBT group showed significantly greater improvement in positive symptoms, negative symptoms, global psychopathology, performance of independent functions and prosocial activities.

Conclusions. The study provides evidence for the feasibility and effectiveness for targeting CBT on the appearance of early signs of relapse in schizophrenia. The results are discussed in context of the study's methodological limitations.

Corresponding author
Dr Andrew Gumley, University of Glasgow, Department of Psychological Medicine, Academic Centre, Garnavel Royal Hospital, 1055 Great Western Road, Glasgow G12 OXH.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *